UB Paderborn / Katalog / Suche / in CDI

Receptor-Fc fusion therapeutics, traps, and MIMETIBODY™ technology

Current opinion in biotechnology, 2009-12, Vol.20 (6), p.692-699

Huang, Chichi

2009

Link zum Volltext

Verfügbarkeit prüfen

GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates

Nature medicine, 2017-10, Vol.23 (10), p.1150-1157

2017

Link zum Volltext

Verfügbarkeit prüfen

Identification and characterization of an unexpected isomerization motif in CDRH2 that affects antibody activity

mAbs, 2023, Vol.15 (1), p.2215364-2215364

2023

Link zum Volltext

Verfügbarkeit prüfen

Accelerating the speed of innovative anti-tumor drugs to first-in-human trials incorporating key de-risk strategies

mAbs, 2023, Vol.15 (1), p.2292305-2292305

2023

Link zum Volltext

Verfügbarkeit prüfen

CNTO 530 increases expression of HbA and HbF in murine models of β-thalassemia and sickle cell anemia

Current pharmaceutical biotechnology, 2013-02, Vol.14 (2), p.242

2013

Link zum Volltext

Verfügbarkeit prüfen

Folding of the β-propeller domain of the integrin αL subunit is independent of the I domain and dependent on the β2 subunit

Proceedings of the National Academy of Sciences - PNAS, 1997-04, Vol.94 (7), p.3162-3167

1997

Link zum Volltext

Verfügbarkeit prüfen

A Binding Interface on the I Domain of Lymphocyte Function-associated Antigen-1 (LFA-1) Required for Specific Interaction with Intercellular Adhesion Molecule 1 (ICAM-1)

The Journal of biological chemistry, 1995-08, Vol.270 (32), p.19008-19016

1995

Link zum Volltext

Verfügbarkeit prüfen

Structural insights into the unique pH-responsive characteristics of the anti-TIGIT therapeutic antibody Ociperlimab

Structure (London), 2024-05, Vol.32 (5), p.550-561.e5

2024

Link zum Volltext

Verfügbarkeit prüfen

Folding of the Conserved Domain but not of Flanking Regions in the Integrin β2Subunit Requires Association with the α Subunit

Proceedings of the National Academy of Sciences - PNAS, 1997-04, Vol.94 (7), p.3156-3161

1997

Link zum Volltext

Verfügbarkeit prüfen

A majority of Ig H chain cDNA of normal human adult blood lymphocytes resembles cDNA for fetal Ig and natural autoantibodies

The Journal of immunology (1950), 1993-11, Vol.151 (10), p.5290

1993

Link zum Volltext

Verfügbarkeit prüfen

Immunoglobulin heavy chain gene expression in peripheral blood B lymphocytes

The Journal of clinical investigation, 1992-04, Vol.89 (4), p.1331-1343

1992

Link zum Volltext

Verfügbarkeit prüfen

Targeting the Ion Channel Kv1.3 with Scorpion Venom Peptides Engineered for Potency, Selectivity, and Half-life

The Journal of biological chemistry, 2014-08, Vol.289 (33), p.22704-22714

2014

Link zum Volltext

Verfügbarkeit prüfen

Structural and Functional Studies with Antibodies to the Integrin β2 Subunit

The Journal of biological chemistry, 2000-07, Vol.275 (28), p.21514-21524

2000

Link zum Volltext

Verfügbarkeit prüfen

Engineering peptide therapeutics using MIMETIBODY™ technology

Methods in molecular biology (Clifton, N.J.), 2014, Vol.1088, p.125

2014

Link zum Volltext

Verfügbarkeit prüfen

The Top of the Inserted-like Domain of the Integrin Lymphocyte Function-associated Antigen-1 β Subunit Contacts the α Subunit β-Propeller Domain near β-Sheet 3

The Journal of biological chemistry, 2000-07, Vol.275 (29), p.22202-22212

2000

Link zum Volltext

Verfügbarkeit prüfen

Folding of the β -Propeller Domain of the Integrin αLSubunit is Independent of the I Domain and Dependent on the β2Subunit

Proceedings of the National Academy of Sciences - PNAS, 1997-04, Vol.94 (7), p.3162-3167

1997

Link zum Volltext

Verfügbarkeit prüfen

Folding of the β-propeller domain of the integrin α L subunit is independent of the I domain and dependent on the β 2 subunit

Proceedings of the National Academy of Sciences - PNAS, 1997-04, Vol.94 (7), p.3162-3167

1997

Link zum Volltext

Verfügbarkeit prüfen

Folding of the beta -propeller domain of the integrin alpha sub(L) subunit is independent of the I domain and dependent on the beta sub(2) subunit

Proceedings of the National Academy of Sciences - PNAS, 1997-04, Vol.94 (7), p.3162-3167

1997

Link zum Volltext

Verfügbarkeit prüfen

Structural and Functional Studies with Antibodies to the Integrin Î²2 Subunit

The Journal of biological chemistry, 2000-07, Vol.275 (28), p.21514

2000

Link zum Volltext

Verfügbarkeit prüfen

Folding of the conserved domain but not of flanking regions in the integrin beta sub(2) subunit requires association with the alpha subunit

Proceedings of the National Academy of Sciences - PNAS, 1997-04, Vol.94 (7), p.3156-3161

1997

Link zum Volltext

Verfügbarkeit prüfen

Folding of the conserved domain but not of flanking regions in the integrin β 2 subunit requires association with the α subunit

Proceedings of the National Academy of Sciences - PNAS, 1997-04, Vol.94 (7), p.3156-3161

1997

Link zum Volltext

Verfügbarkeit prüfen

Identification and characterization of an unexpected isomerization motif in CDRH2 that affects antibody activity

mAbs, 2023, Vol.15 (1)

2023

Link zum Volltext

Verfügbarkeit prüfen

The Top of the Inserted-like Domain of the Integrin Lymphocyte Function-associated Antigen-1 Î² Subunit Contacts the Î± Subunit Î²-Propeller Domain near Î²-Sheet 3

The Journal of biological chemistry, 2000-07, Vol.275 (29), p.22202

2000

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Receptor-Fc fusion therapeutics, traps, and MIMETIBODY™ technology

GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates

Identification and characterization of an unexpected isomerization motif in CDRH2 that affects antibody activity

"Stapling" scFv for multispecific biotherapeutics of superior properties

Accelerating the speed of innovative anti-tumor drugs to first-in-human trials incorporating key de-risk strategies

CNTO 530 increases expression of HbA and HbF in murine models of β-thalassemia and sickle cell anemia

Folding of the β-propeller domain of the integrin αL subunit is independent of the I domain and dependent on the β2 subunit

A Binding Interface on the I Domain of Lymphocyte Function-associated Antigen-1 (LFA-1) Required for Specific Interaction with Intercellular Adhesion Molecule 1 (ICAM-1)

Structural insights into the unique pH-responsive characteristics of the anti-TIGIT therapeutic antibody Ociperlimab

Folding of the Conserved Domain but not of Flanking Regions in the Integrin β2Subunit Requires Association with the α Subunit

A majority of Ig H chain cDNA of normal human adult blood lymphocytes resembles cDNA for fetal Ig and natural autoantibodies

Immunoglobulin heavy chain gene expression in peripheral blood B lymphocytes

Targeting the Ion Channel Kv1.3 with Scorpion Venom Peptides Engineered for Potency, Selectivity, and Half-life

Structural and Functional Studies with Antibodies to the Integrin β2 Subunit

Engineering peptide therapeutics using MIMETIBODY™ technology

The Top of the Inserted-like Domain of the Integrin Lymphocyte Function-associated Antigen-1 β Subunit Contacts the α Subunit β-Propeller Domain near β-Sheet 3

Folding of the β -Propeller Domain of the Integrin αLSubunit is Independent of the I Domain and Dependent on the β2Subunit

Folding of the β-propeller domain of the integrin α L subunit is independent of the I domain and dependent on the β 2 subunit

Folding of the beta -propeller domain of the integrin alpha sub(L) subunit is independent of the I domain and dependent on the beta sub(2) subunit

Structural and Functional Studies with Antibodies to the Integrin Î²2 Subunit

Folding of the conserved domain but not of flanking regions in the integrin beta sub(2) subunit requires association with the alpha subunit

Folding of the conserved domain but not of flanking regions in the integrin β 2 subunit requires association with the α subunit

Identification and characterization of an unexpected isomerization motif in CDRH2 that affects antibody activity

The Top of the Inserted-like Domain of the Integrin Lymphocyte Function-associated Antigen-1 Î² Subunit Contacts the Î± Subunit Î²-Propeller Domain near Î²-Sheet 3

Accelerating the speed of innovative anti-tumor drugs to first-in-human trials incorporating key de-risk strategies

Suchergebnisse filtern